Toxoplasma gondii is an intracellular protozoan that causes toxoplasmosis disease, which is a worldwide infection and has approximately infected one-third of the world’s population (
1,
2). In humans, infection with this parasite is known as a risk factor for the development of schizophrenia and depression (
3-
6). The prevalence of toxoplasmosis is varied from 8.2% to 63.2% and 11.0% to 80% in Europe and American, respectively (
7).
The prevalence of infection in different regions of Iran is varied based on weather conditions. Environmental conditions, such as the changes in humidity and temperature have a direct effect in maintaining sporulation of oocysts excreted by the final host cat (
1). Studies in different regions in Iran show that the seroprevalence of
T. gondii infection was at 39.3% among the general population (
8).
The number of parasites, parasite virulence, genetic background, sex, and immunological status of individuals seem to affect the progression of the infection. Toxoplasmosis has two acute and chronic forms (
9). The chronic form is seen in people who seem to be healthy (
1). Typically, in people with an effective immune system, toxoplasmosis is a benign infection and does not cause a specific problem (
2). The parasite develops cysts in various organs, including different anatomical places of the brain and various types of neurons. Consequently, the infection can cause various hormonal and mental disorders and probably some personality and behavioral changes (
1,
6,
10) like obsessive-compulsive disorder, suicide, Alzheimer’s, Parkinson’s disease, epilepsy, migraine headaches, mental retardation, and behavioral and neurological disorders (
3-
6).
Previous studies have shown the relationship between toxoplasmosis and the phenomenon of anxiety and depression (
5,
6).